Ageusia: Clinical Trials

1 trial for Ageusia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Ageusia: new trials by email Literature Review of Ageusia trials Research Report on Ageusia

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
Cerebrolysin - Covid19 Related Anosmia and Aguesia
Phase 3CompletedAssiut University2502020-08-012023-01-03

Narrower conditions

Anosmia (1)  ·  COVID-19 (1)

Broader conditions

Coronaviridae Infections (1)  ·  Coronavirus Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Nidovirales Infections (1)  ·  Olfaction Disorders (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Sensation Disorders (1)

Interventions

cerebrolysin (1)

Sponsors

Assiut University (1)

Countries

Egypt (1)

Top investigators

Sherifa A Hamed, M.D. (1)

Results publications

PMID 32253535, PMID 37950370